Active Ingredient(s):Pemigatinib FDA Approved: * April 17, 2020 Pharm Company: *INCYTE CORP Category:Cancer
Pemigatinib, sold under the brand name Pemazyre, is an anti-cancer medication used for the treatment of bile duct cancer (cholangiocarcinoma). Pemigatinib works by blocking FGFR2 in tumor cells to prevent them from growing and spreading.
Pemigatinib belongs to a group of medicines called protein kinase inhibitors. It works by blocking enzymes known as protein kinases, particularly...
* May have multiple approval dates, manufacturers, or labelers.